Movano Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Movano şirketinin toplam hissedar öz sermayesi $10.3M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $15.1M ve $4.8M dir.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	n/a
Nakit	US$11.27m
Eşitlik	US$10.25m
Toplam yükümlülükler	US$4.82m
Toplam varlıklar	US$15.07m

Son finansal sağlık güncellemeleri

We're A Little Worried About Movano's (NASDAQ:MOVE) Cash Burn Rate

Aug 29

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MOVE 'nin kısa vadeli varlıkları ( $14.0M ) kısa vadeli yükümlülüklerini ( $4.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: MOVE şirketinin kısa vadeli varlıkları ( $14.0M ) uzun vadeli yükümlülüklerini ( $583.0K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MOVE borçsuzdur.

Borcun Azaltılması: MOVE un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: MOVE şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: MOVE un, serbest nakit akışı her yıl % 25.3 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Movano Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Movano Health Announces Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market

We're A Little Worried About Movano's (NASDAQ:MOVE) Cash Burn Rate

Movano Inc. announced delayed 10-Q filing

Movano Inc. announced delayed annual 10-K filing

Movano Receives Non-Compliance Notice from Nasdaq

Movano Receives Non-Compliance Notice from Nasdaq

Recent updates

Movano Health Announces Completion of Clinical Study with Cuffless Rf Blood Pressure Device

Movano Inc. to Report Q3, 2024 Results on Nov 14, 2024

Movano Health Announces Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market

Movano Health Announces the Immediate Availability of Its Evie Ring

We're A Little Worried About Movano's (NASDAQ:MOVE) Cash Burn Rate

New major risk - Financial position

Movano Inc. to Report Q2, 2024 Results on Aug 14, 2024

Movano Inc., Annual General Meeting, Jul 09, 2024

Movano Inc. announced delayed 10-Q filing

Movano Inc. to Report Q1, 2024 Results on May 15, 2024

Movano Inc. announced that it has received $24.128792 million in funding

Movano Inc. announced that it expects to receive $24.14411 million in funding

Movano Inc. announced that it expects to receive $23.985 million in funding

Movano Inc. announced delayed annual 10-K filing

Movano Health's Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial

Movano Receives Non-Compliance Notice from Nasdaq

Movano Receives Non-Compliance Notice from Nasdaq

Movano Inc. has completed a Follow-on Equity Offering in the amount of $3.600008 million.

Movano Inc. to Report Q3, 2023 Results on Nov 14, 2023

Movano Inc. Appoints Fátima Rodriguez to Its Medical Advisory Board

High number of new and inexperienced directors

Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely

Movano Health Announces the Formation of its Medical Advisory Board

Movano Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Share price stability

New major risk - Shareholder dilution

Here's Why We're A Bit Worried About Movano's (NASDAQ:MOVE) Cash Burn Situation

Can Movano (NASDAQ:MOVE) Afford To Invest In Growth?

Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women

Movano Inc. to Report Q3, 2022 Results on Nov 14, 2022

We Think Movano (NASDAQ:MOVE) Needs To Drive Business Growth Carefully

Movano Inc. Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution

Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission

We Think Movano (NASDAQ:MOVE) Needs To Drive Business Growth Carefully

Movano Inc. Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring

Less than half of directors are independent

Movano Inc. to Report Q1, 2022 Results on May 12, 2022

Less than half of directors are independent

Movano Inc Appoints Nan Kirsten Forte to Its Board of Directors

Movano Inc. Announces Completion of its Second Glucose Pilot Study

Movano Strengthens Intellectual Property for its Non-Invasive Sensor Technology with Three New U.S. Patents

Movano Completes Blood Pressure Study with 110 Participants

Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights

We Think Movano (NASDAQ:MOVE) Can Afford To Drive Business Growth

Companies Like Movano (NASDAQ:MOVE) Are In A Position To Invest In Growth

Health tech company Movano to join Russell Microcap Index

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin